Australian biotech spinoff to develop drugs

By admin
The Australian diagnostics company HealthLinx is spinning off two
therapies in clinical development into a new company--Proaegis
Biosciences--which will hit the road in search of $4 million in fresh
Read more...

http://www.fiercebiotech.com/story/australian-biotech-spinoff-develop-drugs
/2007-10-17?utm_medium=rss&utm_source=rss

http://www.fiercebiotech.com/news/frontpage


Biotech News
AZhttp, Inc.
Biotechnology Marketing